# Observation of the Use of QUTENZA™ in Standard Clinical Practice

> **NCT01737294** · — · COMPLETED · sponsor: **Astellas Pharma Europe Ltd.** · enrollment: 429 (actual)

## Conditions studied

- Peripheral Neuropathic Pain

## Interventions

- **DRUG:** Qutenza exposure

## Key facts

- **NCT ID:** NCT01737294
- **Lead sponsor:** Astellas Pharma Europe Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 429 (ACTUAL)
- **Last updated:** 2014-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01737294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01737294, "Observation of the Use of QUTENZA™ in Standard Clinical Practice". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01737294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*